Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Sell
68,923
-12,258
-15% -$23.4K ﹤0.01% 4006
2025
Q4
$175K Buy
81,181
+7,430
+10% +$25.4K ﹤0.01% 4395
2025
Q3
$355K Buy
73,751
+61,787
+516% +$337K ﹤0.01% 3995
2025
Q2
$66.4K Buy
11,964
+3,745
+46% +$29.6K ﹤0.01% 4660
2025
Q1
$101K Sell
8,219
-2,285
-22% -$34.9K ﹤0.01% 4408
2024
Q4
$141K Buy
10,504
+924
+10% +$10.5K ﹤0.01% 4480
2024
Q3
$89.9K Buy
9,580
+4,372
+84% +$44.3K ﹤0.01% 4600
2024
Q2
$50.6K Sell
5,208
-1,325
-20% -$13.1K ﹤0.01% 4211
2024
Q1
$68.7K Sell
6,533
-2,801
-30% -$34.6K ﹤0.01% 4544
2023
Q4
$125K Buy
9,334
+4,978
+114% +$68.1K ﹤0.01% 4582
2023
Q3
$63.1K Sell
4,356
-70
-2% -$1.21K ﹤0.01% 3766
2023
Q2
$87.2K Sell
4,426
-4,675
-51% -$73.4K ﹤0.01% 3606
2023
Q1
$148K Buy
9,101
+5,455
+150% +$84.2K ﹤0.01% 3968
2022
Q4
$38.1K Sell
3,646
-13
-0.4% -$115 ﹤0.01% 4644
2022
Q3
$19K Sell
3,659
-1,322
-27% -$9.95K ﹤0.01% 4080
2022
Q2
$45K Sell
4,981
-949
-16% -$11K ﹤0.01% 4072
2022
Q1
$104K Buy
+5,930
New +$185K ﹤0.01% 3760

Other funds holding GOCO

Barclays's GOCO Position: Q1 2026 in Review

Barclays reduced its GoHealth (GOCO) stake by 15% in Q1 2026, selling an estimated $23.4K and leaving 68,923 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #4006.

Barclays first reported a position in GOCO in Q1 2022 and has held it in 17 quarters since. The position peaked at $355K in Q3 2025. 67 funds tracked by Wall St. Rank hold GOCO as of Q1 2026.

  • Barclays held 68,923 shares of GoHealth worth $104K as of Q1 2026.
  • Barclays sold 12,258 GoHealth shares in Q1 2026, an estimated $23.4K.
  • GoHealth made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4006 holding.
  • Barclays first reported a position in GoHealth in Q1 2022 and has held it in 17 quarters since.
  • Barclays's GoHealth position peaked at $355K in Q3 2025.
  • 67 funds tracked by Wall St. Rank held GoHealth as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.